In the CHCC cohort, HCC patients with high expression of CDK1 (Additional file 3: Figure S3A; P < 0.001) and CDK4 (Additional file 3: Figure S3B; P < 0.001) had statistically worse prognosis. This evidence concerns the gene CDK4 and hepatocellular carcinoma.